These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25841715)

  • 1. Mantle cell lymphoma-management in evolution.
    Rajguru S; Kahl BS
    Chin Clin Oncol; 2015 Mar; 4(1):8. PubMed ID: 25841715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel therapies in mantle cell lymphoma: a pathway to chemotherapy-free strategies.
    Nastoupil LJ; Koff JL; Flowers CR
    Oncology (Williston Park); 2013 Oct; 27 Suppl 2():8-12. PubMed ID: 25374999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mantle Cell Lymphoma: First-line Therapy in Patients Not Eligible for Stem Cell Transplantation.
    Nazeef M; Kahl BS
    Curr Treat Options Oncol; 2015 Jun; 16(6):29. PubMed ID: 25975443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the management of mantle cell lymphoma.
    Rivera-Rodriguez N; Cabanillas F
    Curr Opin Oncol; 2013 Nov; 25(6):716-21. PubMed ID: 24076580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging agents for the treatment of mantle cell lymphoma.
    Camara-Clayette V; Hermine O; Ribrag V
    Expert Rev Anticancer Ther; 2012 Sep; 12(9):1205-15. PubMed ID: 23098120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging therapy for the treatment of mantle cell lymphoma.
    Rajguru S; Kahl BS
    J Natl Compr Canc Netw; 2014 Sep; 12(9):1311-8; quiz 1318. PubMed ID: 25190697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment strategies in mantle cell lymphoma.
    Maddocks K; Blum KA
    Cancer Treat Res; 2015; 165():251-70. PubMed ID: 25655613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy and safety in relapsed/refractory mantle cell lymphoma: a systematic literature review.
    Njue A; Colosia A; Trask PC; Olivares R; Khan S; Abbe A; Police R; Wang J; Ruiz-Soto R; Kaye JA; Awan F
    Clin Lymphoma Myeloma Leuk; 2015 Jan; 15(1):1-12.e7. PubMed ID: 25052050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mantle cell lymphoma: the promise of new treatment options.
    Goy A; Kahl B
    Crit Rev Oncol Hematol; 2011 Oct; 80(1):69-86. PubMed ID: 21168343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in Molecular Biology and Targeted Therapy of Mantle Cell Lymphoma.
    Klener P
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emerging role of lenalidomide in the management of mantle cell lymphoma (MCL).
    Dawar R; Hernandez-Ilizaliturri F
    Best Pract Res Clin Haematol; 2012 Jun; 25(2):185-90. PubMed ID: 22687454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents.
    Inamdar AA; Goy A; Ayoub NM; Attia C; Oton L; Taruvai V; Costales M; Lin YT; Pecora A; Suh KS
    Oncotarget; 2016 Jul; 7(30):48692-48731. PubMed ID: 27119356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of mantle cell lymphoma: key challenges and next steps.
    Williams ME; Dreyling M; Winter J; Muneer S; Leonard JP
    Clin Lymphoma Myeloma Leuk; 2010 Oct; 10(5):336-46. PubMed ID: 21030346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current strategies in the treatment of advanced stage mantle cell lymphoma].
    Lenz G; Dreyling M; Unterhalt M; Hiddemann W
    Dtsch Med Wochenschr; 2004 Nov; 129(45):2429-33. PubMed ID: 15529247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel agents in mantle cell lymphoma.
    Tucker D; Rule S
    Expert Rev Anticancer Ther; 2017 Jun; 17(6):491-506. PubMed ID: 28480764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of relapsed/refractory mantle cell lymphoma: a review of current therapeutic strategies.
    Zaja F; Federico M; Vitolo U; Zinzani PL
    Leuk Lymphoma; 2014 May; 55(5):988-98. PubMed ID: 23865835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mantle cell lymphoma in relapse: the role of emerging new drugs.
    Diefenbach CS; O'Connor OA
    Curr Opin Oncol; 2010 Sep; 22(5):419-23. PubMed ID: 20679769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment for patients with relapsed/refractory mantle cell lymphoma: European-based recommendations.
    Dreyling M; Aurer I; Cortelazzo S; Hermine O; Hess G; Jerkeman M; Le Gouill S; Ribrag V; Trněný M; Visco C; Walewski J; Zaja F; Zinzani PL
    Leuk Lymphoma; 2018 Aug; 59(8):1814-1828. PubMed ID: 29172868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current treatment approaches for mantle-cell lymphoma.
    Witzig TE
    J Clin Oncol; 2005 Sep; 23(26):6409-14. PubMed ID: 16155027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.